Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GENEX logo — Harnessing genomic insights for breakthroughs in drug discov...

GENEX

Harnessing genomic insights for breakthroughs in drug discovery, development, and disease diagnosis through secure, comprehensive molecular testing solutions.

Founded 2019 Seed Health Care

General Information

Company Name GENEX
Founded Year 2019
Industries Health Care
Funding Stage Seed
Social

Get notified when GENEX moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GENEX

GENEX is a health care startup founded in 2019 with a strong focus on harnessing genomic insights for breakthroughs in drug discovery, development, and disease diagnosis through secure, comprehensive molecular testing solutions. The company provides comprehensive genome molecular testing services to the pharmaceutical sector and its supporting organizations. Their offerings encompass drug discovery and development pipelines along with essential services such as documentation, ethics procedures, patient outreach, electronic informed consent, sample collection, genomic analysis, and data storage and management. With secure cloud-based storage for genomic information, they facilitate diagnoses and clinical trials for mitochondrial disease. GENEX's Seed Round investment at 29 January 2021 was backed by notable investors including Monex Ventures, Kaken Pharmaceutical, and Sugi Medicine. This innovative startup presents an exciting opportunity for potential investors looking to tap into the rapidly evolving genomics and molecular testing market.

Taxonomy: genomic insights, drug discovery, development, disease diagnosis, molecular testing, pharmaceutical sector, documentations, ethics procedures, patient outreach, genomic analysis, data storage, clinical trials, secure cloud storage, mitochondrial disease

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 3
Investor
•••• •••• 		29 Jan 2021

GENEX Alternatives & Competitors

GENEX vs
PetaGene
PetaGene United Kingdom

Secure transparent compression

Acquired
4 employees
Biotechnology
GENEX vs
J. Craig Venter Institute
J. Craig Venter Institute United States

Pioneering Genomics to Positively Impact Life

Grant
204 employees
Biotechnology, Health Care
GENEX vs
AyuGen Biosciences Pvt Ltd
AyuGen Biosciences Pvt Ltd

Science Behind Life

2 employees
Pharmaceutical

FAQ About GENEX

Harnessing genomic insights for breakthroughs in drug discovery, development, and disease diagnosis through secure, comprehensive molecular testing solutions.
GENEX was founded in 2019.
GENEX operates in the following industries: Health Care.
GENEX has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to GENEX include PetaGene, J. Craig Venter Institute, AyuGen Biosciences Pvt Ltd, GenomSys, Merogenomics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GENEX and PetaGene are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GENEX and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes